Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide.

@article{Chrysant2004EvaluationOA,
  title={Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide.},
  author={Steven G Chrysant and Michael D Weber and Antonia C. Wang and Donald J Hinman},
  journal={American journal of hypertension},
  year={2004},
  volume={17 3},
  pages={252-9}
}
BACKGROUND Most patients with hypertension require more than one agent to control blood pressure (BP). The purpose of this study was to assess the efficacy and safety of the angiotensin II receptor blocker olmesartan medoxomil in combination with hydrochlorothiazide (HCTZ). METHODS This was a randomized, double-blind, factorial design study. After a placebo run-in period, eligible patients (n = 502) with a baseline mean seated diastolic blood pressure (SeDBP) of 100 to 115 mm Hg were… CONTINUE READING
47 Citations
44 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 47 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 44 references

Diabetic nephropathy

  • JM Neutel
  • Diabetes Care
  • 2002

Similar Papers

Loading similar papers…